Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 24 (RPL7AP24)

Target: RPL7AP24
Molecular classification: Other (processed pseudogene)

Overview

"Ribosomal protein L7a pseudogene 24" (RPL7AP24) is a processed pseudogene derived from the functional RPL7A gene, which encodes a component of the 60S ribosomal subunit. Pseudogenes are incomplete gene copies that typically do not produce functional proteins. There is no established biological, therapeutic, or diagnostic relevance for this pseudogene[2][5]. When describing the ribosomal protein L7a itself, it participates in protein synthesis as part of the ribosome, but the pseudogene version does not share these functions. If seeking a therapeutic or functional target, refer to the canonical ribosomal protein L7a (RPL7A), not the pseudogene RPL7AP24.

Other names: RPL7AP24RPL7A_6_424

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 24 (RPL7AP24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 24 (RPL7AP24).

Explore the full profile